ProQR Therapeutics (PRQR)
(Delayed Data from NSDQ)
$1.78 USD
-0.04 (-2.20%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $1.77 -0.01 (-0.56%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.12 | 0.00% |
Earnings Summary
For their last quarter, ProQR Therapeutics (PRQR) reported earnings of -$0.10 per share, beating the Zacks Consensus Estimate of $-0.12 per share. This reflects a positive earnings surprise of 16.67%. Look out for PRQR's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.12 per share, reflecting a year-over-year decrease of 9.09%.
Earnings History
Price & Consensus
Zacks News for PRQR
Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Misses Revenue Estimates
PRQR: What are Zacks experts saying now?
Zacks Private Portfolio Services